Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Analysis of Long-term (Investment) Activity Ratios
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Long-term Activity Ratios (Summary)

Medtronic PLC, long-term (investment) activity ratios (quarterly data)

Microsoft Excel
Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020 Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019
Net fixed asset turnover
Total asset turnover
Equity turnover

Based on: 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31), 10-K (reporting date: 2020-04-24), 10-Q (reporting date: 2020-01-24), 10-Q (reporting date: 2019-10-25), 10-Q (reporting date: 2019-07-26).


Net Fixed Asset Turnover
The net fixed asset turnover ratio exhibits a general declining trend from the initial available data point of 5.99 in April 2020 to 4.91 by April 2025. Early fluctuations show a slight decrease from 5.99 to 5.56 in April 2020 through April 2021, followed by a moderate recovery peaking at 6.13 in October 2021. After this peak, the ratio steadily declines, indicating a somewhat diminishing efficiency in utilizing fixed assets to generate sales over the observed period.
Total Asset Turnover
This ratio demonstrates a gradual upward trend from 0.32 in April 2020 to approximately 0.37 in the later periods approaching April 2025. Initial values are relatively stable around the 0.29 to 0.30 range through 2020, with subsequent quarterly increments reflecting improving efficiency in the use of total assets for revenue generation. The steady increase suggests enhancements in asset utilization or growth in sales relative to total asset base over time.
Equity Turnover
Equity turnover shows a consistent increase across the available periods, starting at 0.57 in April 2020 and climbing to 0.70 by April 2025. This upward trajectory indicates progressively improved utilization of shareholder equity in generating sales. Early data points remain relatively flat with minor increments, but from mid-2021 onward, the ratio increases more noticeably, pointing to strengthening operational efficiency or increased sales relative to equity.

Net Fixed Asset Turnover

Medtronic PLC, net fixed asset turnover calculation (quarterly data)

Microsoft Excel
Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020 Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019
Selected Financial Data (US$ in millions)
Net sales
Property, plant, and equipment, net
Long-term Activity Ratio
Net fixed asset turnover1
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31), 10-K (reporting date: 2020-04-24), 10-Q (reporting date: 2020-01-24), 10-Q (reporting date: 2019-10-25), 10-Q (reporting date: 2019-07-26).

1 Q4 2025 Calculation
Net fixed asset turnover = (Net salesQ4 2025 + Net salesQ3 2025 + Net salesQ2 2025 + Net salesQ1 2025) ÷ Property, plant, and equipment, net
= ( + + + ) ÷ =

2 Click competitor name to see calculations.


Net Sales
Net sales exhibited fluctuations over the analyzed periods. Initially, sales increased from 7,493 million US dollars in July 2019 to 7,717 million in January 2020, followed by a significant decline to 5,997 million in April 2020, likely impacted by external factors such as market disruptions. Subsequently, there was a recovery trend, with sales reaching 8,544 million by April 2023. However, this was followed by some variability, with sales figures oscillating between approximately 7,371 million and 8,927 million in the most recent quarters. Overall, the trend suggests resilience and recovery with some short-term volatility in net sales performance.
Property, Plant, and Equipment, Net
A steady upward trend was observed in the net value of property, plant, and equipment, increasing consistently from 4,711 million US dollars in July 2019 to 6,837 million in April 2025. This growth reflects ongoing investments in fixed assets, with an average incremental increase each quarter, indicating a commitment to expanding or upgrading physical capital over the period reviewed.
Net Fixed Asset Turnover
The net fixed asset turnover ratio showed a gradual decline throughout the periods for which data is available. Initially high at 5.99 in April 2020, the ratio decreased progressively to 4.91 by April 2025. This downward trend suggests that while the company has increased its investment in fixed assets, the efficiency with which these assets are utilized to generate net sales has diminished over time. The reduction in turnover ratio could point to either slower sales growth relative to asset base expansion or less effective use of fixed assets.
Summary of Trends and Insights
The overall analysis reveals that the company has experienced some volatility in net sales, including a significant decline around early 2020, followed by recovery and periodic fluctuations. Investment in fixed assets has steadily increased, demonstrating expansion or modernization efforts. However, the declining net fixed asset turnover ratio indicates a potential decrease in asset utilization efficiency, which may warrant further operational review. Maintaining or improving sales growth relative to asset expansion appears to be a key area for strategic focus going forward.

Total Asset Turnover

Medtronic PLC, total asset turnover calculation (quarterly data)

Microsoft Excel
Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020 Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019
Selected Financial Data (US$ in millions)
Net sales
Total assets
Long-term Activity Ratio
Total asset turnover1
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31), 10-K (reporting date: 2020-04-24), 10-Q (reporting date: 2020-01-24), 10-Q (reporting date: 2019-10-25), 10-Q (reporting date: 2019-07-26).

1 Q4 2025 Calculation
Total asset turnover = (Net salesQ4 2025 + Net salesQ3 2025 + Net salesQ2 2025 + Net salesQ1 2025) ÷ Total assets
= ( + + + ) ÷ =

2 Click competitor name to see calculations.


Net Sales
The net sales exhibit a fluctuating yet generally upward trend over the observed periods. Starting at 7,493 million US dollars in July 2019, sales experienced a noticeable dip in April 2020 to 5,997 million, likely reflecting an adverse event during that period. Subsequently, sales recovered and generally increased, reaching a peak of 8,589 million in April 2024. However, some quarters, such as July 2022 and July 2024, show intermittent declines or plateau phases. Overall, the trend signals resilience and moderate growth with some seasonal or external fluctuations affecting quarterly results.
Total Assets
Total assets remained relatively stable throughout the period, hovering around the 90,000 million US dollars mark. Beginning at 91,268 million in July 2019, assets showed minor fluctuations without any significant upward or downward trend. Peaks include 97,270 million in January 2021 and a smaller peak at 94,134 million in January 2023. In contrast, some declines are observed in 2021 and 2023, but total assets generally maintain a consistent level, suggesting steady asset management without major acquisitions or disposals.
Total Asset Turnover
The total asset turnover ratio data starts from the quarter ended April 2020. The ratio shows a gradual increase from 0.30 in April 2020 to 0.37 by January 2025, indicating improved efficiency in using assets to generate sales. This steady upswing suggests that the company is increasingly effective at leveraging its asset base to produce revenue. The consistent rise in this ratio, despite relatively stable total assets, reinforces that sales growth is outpacing asset expansion.
Overall Insights
The combination of stable total assets and increasing asset turnover ratios points to enhanced operational efficiency. While net sales experienced a dip corresponding to external disruptions in early 2020, they rebounded strongly thereafter with moderate growth. The company appears to be optimizing asset use effectively, leading to improved sales generation per unit of asset. Maintaining stable asset levels alongside rising sales may reflect prudent capital management and focus on operational performance improvements.

Equity Turnover

Medtronic PLC, equity turnover calculation (quarterly data)

Microsoft Excel
Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020 Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019
Selected Financial Data (US$ in millions)
Net sales
Shareholders’ equity
Long-term Activity Ratio
Equity turnover1
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31), 10-K (reporting date: 2020-04-24), 10-Q (reporting date: 2020-01-24), 10-Q (reporting date: 2019-10-25), 10-Q (reporting date: 2019-07-26).

1 Q4 2025 Calculation
Equity turnover = (Net salesQ4 2025 + Net salesQ3 2025 + Net salesQ2 2025 + Net salesQ1 2025) ÷ Shareholders’ equity
= ( + + + ) ÷ =

2 Click competitor name to see calculations.


The financial data reveals several notable trends over the analyzed periods.

Net Sales
Net sales showed some volatility, with a significant decline observed in April 2020, dropping from 7,717 million USD in January 2020 to 5,997 million USD. This drop likely reflects external disruptions impacting sales during that quarter. Following this dip, net sales recovered gradually, reaching a peak of 8,589 million USD in April 2024. Throughout the timeline, net sales mostly fluctuated between approximately 7,300 million USD and 8,800 million USD, demonstrating resilience and a general upward recovery trend after the dip.
Shareholders’ Equity
Shareholders' equity displayed a downward trend over the period. Starting at 50,363 million USD in July 2019, it maintained relative stability with slight fluctuations until mid-2022. From mid-2022 onward, equity showed a declining trajectory, falling to 48,024 million USD by April 2025. This decline suggests either distributions, share repurchases, or other equity reductions surpassing retained earnings or capital inflows.
Equity Turnover Ratio
Equity turnover, beginning with data in April 2020, showed a consistent upward trend. Initially around 0.55 to 0.57, the ratio increased steadily to reach 0.70 by April 2025. The rising equity turnover ratio indicates improving efficiency in using shareholders' equity to generate sales. This improvement complements the rebound and growth in net sales, especially as equity declined during the same timeframe.

In summary, the company experienced a sharp sales decline in early 2020 followed by sustained recovery and growth in sales figures. Despite the growth in net sales, shareholders' equity decreased over time. The equity turnover ratio improved considerably, reflecting enhanced operational efficiency in generating revenue from the equity base. These insights suggest a focus on leveraging shareholders' equity more effectively amidst changes in the capital structure or retained earnings during the periods reviewed.